-
3 Pain and Anti-Malarial Brand Owner, Contract Formulations Maker and Branded Generics Exporter Stocks With a Strong Future Roadmap: Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals
- October 26, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
No Comments
Formulation and Branded Generic Pharma Stocks with a strong future roadmap: Ipca Laboratories, Innova Captab and Lincoln Pharmaceuticals. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.
-
3 Oncology and Biologics, Formulation Outsourcing and Eye and Skin Care Brands Stocks With a Strong Future Roadmap: Shilpa Medicare, Innova Captab and Ajanta Pharma
- October 22, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Oncology and Contract Pharma Stocks with a strong future roadmap: Shilpa Medicare, Innova Captab and Ajanta Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.
-
3 Global Generics, Branded Generics and Contract Formulations Stocks With a Strong Future Roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Generic and Branded Pharma Stocks with a strong future roadmap: Aurobindo Pharma, Emcure Pharmaceuticals and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Drug Discovery Services, Branded Formulations and Contract Manufacturing Stocks With a Strong Future Roadmap: Sai Life Sciences, Eris Lifesciences and Innova Captab
- October 21, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Pharma Services Stocks with a strong future roadmap: Sai Life Sciences, Eris Lifesciences and Innova Captab. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.
-
3 Pharma Cdmo and Distribution Stocks With a Strong Future Roadmap: Innova Captab, Entero Healthcare Solutions and Alembic Pharmaceuticals
- October 8, 2026
- Posted by: Lakshit Sharma
- Category: Best Stocks
Innova Captab, Entero Healthcare Solutions and Alembic Pharmaceuticals compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
This Oral Solid Dosage Stock Rises 87% in 6 Months: What Is Fueling the Rally?
- September 24, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
One pharma contract manufacturer of tablets and capsules has surged over the past six months, recovering sharply after a weak start to the year. Here is what powered the rally and the risks that remain.
-
This Contract Manufacturing Pharma Stock Rises 33% in 1 Year: What Changed at the Jammu Plant
- September 18, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
One Baddi-based formulations maker gained about 33% in twelve months, almost all of it after March 2026. Here is what changed at its newest plant, and what still worries the market.
- 1
- 2